397 related articles for article (PubMed ID: 16284400)
1. Soluble interleukin-15 receptor alpha (IL-15R alpha)-sushi as a selective and potent agonist of IL-15 action through IL-15R beta/gamma. Hyperagonist IL-15 x IL-15R alpha fusion proteins.
Mortier E; Quéméner A; Vusio P; Lorenzen I; Boublik Y; Grötzinger J; Plet A; Jacques Y
J Biol Chem; 2006 Jan; 281(3):1612-9. PubMed ID: 16284400
[TBL] [Abstract][Full Text] [Related]
2. Natural, proteolytic release of a soluble form of human IL-15 receptor alpha-chain that behaves as a specific, high affinity IL-15 antagonist.
Mortier E; Bernard J; Plet A; Jacques Y
J Immunol; 2004 Aug; 173(3):1681-8. PubMed ID: 15265897
[TBL] [Abstract][Full Text] [Related]
3. The exon-3-encoded domain of IL-15ralpha contributes to IL-15 high-affinity binding and is crucial for the IL-15 antagonistic effect of soluble IL-15Ralpha.
Bouchaud G; Garrigue-Antar L; Solé V; Quéméner A; Boublik Y; Mortier E; Perdreau H; Jacques Y; Plet A
J Mol Biol; 2008 Sep; 382(1):1-12. PubMed ID: 18656487
[TBL] [Abstract][Full Text] [Related]
4. Different dynamics of IL-15R activation following IL-15 cis- or trans-presentation.
Perdreau H; Mortier E; Bouchaud G; Solé V; Boublik Y; Plet A; Jacques Y
Eur Cytokine Netw; 2010 Dec; 21(4):297-307. PubMed ID: 21078585
[TBL] [Abstract][Full Text] [Related]
5. The roles of interleukin-15 receptor alpha: trans-presentation, receptor component, or both?
Schluns KS; Stoklasek T; Lefrançois L
Int J Biochem Cell Biol; 2005 Aug; 37(8):1567-71. PubMed ID: 15896666
[TBL] [Abstract][Full Text] [Related]
6. A potential role for interleukin-15 in the regulation of human natural killer cell survival.
Carson WE; Fehniger TA; Haldar S; Eckhert K; Lindemann MJ; Lai CF; Croce CM; Baumann H; Caligiuri MA
J Clin Invest; 1997 Mar; 99(5):937-43. PubMed ID: 9062351
[TBL] [Abstract][Full Text] [Related]
7. Mast cells express novel functional IL-15 receptor alpha isoforms.
Bulanova E; Budagian V; Orinska Z; Krause H; Paus R; Bulfone-Paus S
J Immunol; 2003 May; 170(10):5045-55. PubMed ID: 12734349
[TBL] [Abstract][Full Text] [Related]
8. Distinct cell types control lymphoid subset development by means of IL-15 and IL-15 receptor alpha expression.
Schluns KS; Nowak EC; Cabrera-Hernandez A; Puddington L; Lefrançois L; Aguila HL
Proc Natl Acad Sci U S A; 2004 Apr; 101(15):5616-21. PubMed ID: 15060278
[TBL] [Abstract][Full Text] [Related]
9. The Sushi domain of soluble IL-15 receptor alpha is essential for binding IL-15 and inhibiting inflammatory and allogenic responses in vitro and in vivo.
Wei Xq ; Orchardson M; Gracie JA; Leung BP; Gao Bm ; Guan H; Niedbala W; Paterson GK; McInnes IB; Liew FY
J Immunol; 2001 Jul; 167(1):277-82. PubMed ID: 11418660
[TBL] [Abstract][Full Text] [Related]
10. Distribution of IL-15 receptor alpha-chains on human peripheral blood mononuclear cells and effect of immunosuppressive drugs on receptor expression.
Chae DW; Nosaka Y; Strom TB; Maslinski W
J Immunol; 1996 Oct; 157(7):2813-9. PubMed ID: 8816384
[TBL] [Abstract][Full Text] [Related]
11. Interaction of IL-15 with the shared IL-2 receptor beta and gamma c subunits. The IL-15/beta/gamma c receptor-ligand complex is less stable than the IL-2/beta/gamma c receptor-ligand complex.
de Jong JL; Farner NL; Widmer MB; Giri JG; Sondel PM
J Immunol; 1996 Feb; 156(4):1339-48. PubMed ID: 8568232
[TBL] [Abstract][Full Text] [Related]
12. Differential effects of interleukin-15 and interleukin-2 on differentiation of bipotential T/natural killer progenitor cells.
Leclercq G; Debacker V; de Smedt M; Plum J
J Exp Med; 1996 Aug; 184(2):325-36. PubMed ID: 8760786
[TBL] [Abstract][Full Text] [Related]
13. Converting IL-15 to a superagonist by binding to soluble IL-15R{alpha}.
Rubinstein MP; Kovar M; Purton JF; Cho JH; Boyman O; Surh CD; Sprent J
Proc Natl Acad Sci U S A; 2006 Jun; 103(24):9166-71. PubMed ID: 16757567
[TBL] [Abstract][Full Text] [Related]
14. Formation of an active form of the interleukin-2/15 receptor beta-chain by insertion of the intracisternal A particle in a radiation-induced mouse thymic lymphoma and its role in tumorigenesis.
Ukai H; Ishii-Oba H; Ukai-Tadenuma M; Ogiu T; Tsuji H
Mol Carcinog; 2003 Jun; 37(2):110-9. PubMed ID: 12766910
[TBL] [Abstract][Full Text] [Related]
15. IL-15 promotes the survival of naive and memory phenotype CD8+ T cells.
Berard M; Brandt K; Bulfone-Paus S; Tough DF
J Immunol; 2003 May; 170(10):5018-26. PubMed ID: 12734346
[TBL] [Abstract][Full Text] [Related]
16. Role for IL-15/IL-15 receptor beta-chain in natural killer 1.1+ T cell receptor-alpha beta+ cell development.
Ohteki T; Ho S; Suzuki H; Mak TW; Ohashi PS
J Immunol; 1997 Dec; 159(12):5931-5. PubMed ID: 9550390
[TBL] [Abstract][Full Text] [Related]
17. Interleukin 15 and its receptor.
Cosman D; Kumaki S; Ahdieh M; Eisenman J; Grabstein KH; Paxton R; DuBose R; Friend D; Park LS; Anderson D
Ciba Found Symp; 1995; 195():221-9; discussion 229-33. PubMed ID: 8724840
[TBL] [Abstract][Full Text] [Related]
18. A protective role of interleukin-15 in a mouse model for systemic infection with herpes simplex virus.
Tsunobuchi H; Nishimura H; Goshima F; Daikoku T; Suzuki H; Nakashima I; Nishiyama Y; Yoshikai Y
Virology; 2000 Sep; 275(1):57-66. PubMed ID: 11017787
[TBL] [Abstract][Full Text] [Related]
19. IL-15:IL-15 receptor alpha superagonist complex: high-level co-expression in recombinant mammalian cells, purification and characterization.
Han KP; Zhu X; Liu B; Jeng E; Kong L; Yovandich JL; Vyas VV; Marcus WD; Chavaillaz PA; Romero CA; Rhode PR; Wong HC
Cytokine; 2011 Dec; 56(3):804-10. PubMed ID: 22019703
[TBL] [Abstract][Full Text] [Related]
20. Interleukin (IL)-15 induces survival and proliferation of the growth factor-dependent acute myeloid leukemia M-07e through the IL-2 receptor beta/gamma.
Meazza R; Basso S; Gaggero A; Detotero D; Trentin L; Pereno R; Azzarone B; Ferrini S
Int J Cancer; 1998 Oct; 78(2):189-95. PubMed ID: 9754651
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
